Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-22

Clinical Trial Update: Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?

View source ↗

Summary

A Mayo Clinic-sponsored study on proton pump inhibitor-responsive eosinophilic esophagitis has completed, investigating whether PPI response can distinguish GER…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Erosive Esophagitis | Status: COMPLETED